Patient Resources

Our patient resources are designed to help you understand, manage, and live well with neuroendocrine cancer.

Here you’ll find practical tools and information to guide you through every stage of your journey, from diagnosis and treatment to living with neuroendocrine cancer day to day.

These resources are created and reviewed by experts to ensure they’re accurate, reliable, and easy to understand.

Filter by:
Or browse by popular tag:

If you are unsure of any information, please contact our NET Nurses on 1300 287 363 or speak with your healthcare professional.

Should you require fact sheets in another language please click through below to the International Neuroendocrine Cancer Alliance (INCA) website fact sheet area for Arabic, Chinese (Mandarin), English, French, German, Hindi, Italian, Japanese, Russian and Spanish versions.

Educational Videos, Explainer Videos

Peptide receptor radionuclide therapy (PRRT)

Forum Videos

Perth NET Patient Forum 2023

Clinical Trials

Phase 3 Trial of CAM2029 vs Standard Treatments in GEP-NET Patients

The purpose of this study is to compare the effectiveness and safety of CAM2029 to octreotide LAR or lanreotide ATG in patients with advanced, well-differentiated GEP-NET.
Causes & Risk Factors

Potential Carcinogens and Neuroendocrine Tumour Risk

Wellness

Preparing for the holiday season

Wellness

Problem-Solving during a Neuroendocrine Cancer Diagnosis

Prognosis

Prognosis in Rare and Aggressive Neuroendocrine Cancers

Prognosis

Prognostic Significance of Tumour Grade in NETs

Fact Sheets
Treatment Options

PRRT Treatment

Fact Sheets

Psychological Tips and Mental Health

Fact Sheets

Questions to Ask

Educational Videos

Questions to ask your Doctor

Fact Sheets

Quick Facts

Fact Sheets

Radiation Therapy

Treatment Options

Radiation Therapy Treatment

Tax Appeal

Screenshot 2026-05-20 at 2.12.07 PM

Help 31,000+ neuroendocrine cancer patients get the specialised care they deserve.

Every dollar raised is fully tax deductible and helps fund much needed advocacy efforts and patient support.